Chen Huanwen, Khunte Mihir, Colasurdo Marco, Singh Paul, Malhotra Ajay, Gandhi Dheeraj
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA,
Department of Neurology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA,
Cerebrovasc Dis. 2024;53(5):519-526. doi: 10.1159/000534821. Epub 2023 Nov 6.
Endovascular treatment (EVT) is a therapeutic option for cerebral venous thrombosis (CVT); however, its benefit over conservative medical management has not been proven. Whether the current patient selection practices are appropriate for EVT is unclear.
This was a nationwide study of the 2016-2020 National Inpatient Sample database. Adult CVT patients and EVT treatments were identified. Patient demographics, medical comorbidities, CVT risk factors, and CVT manifestations were identified. Presence of radiographic signs of advanced and severe CVT (venous infarction, cerebral edema, and intracranial hemorrhage) was recorded. Primary and secondary outcomes were good discharge outcomes and in-hospital mortality, respectively.
A total of 17,130 CVT patients were identified, and 56.7% had good discharge outcomes, while 4.6% died during hospitalization. 945 (5.5%) received EVT, and EVT patients were more likely to have cerebral infarction (35.4 vs. 21.8%, p < 0.001), edema (35.4 vs. 20.1%, p < 0.001), and hemorrhage (37.6 vs. 19.7%, p < 0.001). After multivariable adjustments, EVT for patients without infarction, edema, or hemorrhage was moderately associated with higher odds of good outcomes (OR 1.86 [95% CI 0.98-3.53], p = 0.059) and resulted in zero deaths. However, with the increasing burden of radiographic signs of advanced CVT measured by the cumulative presence of infarction, edema, and hemorrhage, EVT was associated with decreasing odds of good outcomes and increasing odds of in-hospital mortality compared to medical management (interaction p = 0.046 and 0.029, respectively).
EVT may lead to higher rates of favorable hospitalization outcomes in patients who have not yet developed overt parenchymal manifestations of backpressure changes; presence of infarction, edema, and hemorrhage may diminish the short-term effectiveness of EVT.
血管内治疗(EVT)是脑静脉血栓形成(CVT)的一种治疗选择;然而,其相较于保守药物治疗的益处尚未得到证实。目前的患者选择方法是否适用于EVT尚不清楚。
这是一项对2016 - 2020年全国住院患者样本数据库的全国性研究。确定了成年CVT患者和EVT治疗情况。确定了患者的人口统计学特征、合并症、CVT危险因素和CVT表现。记录了晚期和严重CVT的影像学征象(静脉梗死、脑水肿和颅内出血)的存在情况。主要和次要结局分别是良好的出院结局和住院死亡率。
共确定了17130例CVT患者,56.7%的患者有良好出院结局,4.6%的患者在住院期间死亡。945例(5.5%)接受了EVT,接受EVT的患者更有可能发生脑梗死(35.4%对21.8%,p < 0.001)、水肿(35.4%对20.1%,p < 0.001)和出血(37.6%对19.7%,p < 0.001)。经过多变量调整后,对没有梗死、水肿或出血的患者进行EVT与良好结局的较高几率中度相关(比值比1.86 [95%置信区间0.98 - 3.53],p = 0.059),且导致零死亡。然而,随着通过梗死、水肿和出血的累积存在来衡量的晚期CVT影像学征象负担增加,与药物治疗相比,EVT与良好结局几率降低和住院死亡率几率增加相关(交互作用p分别为0.046和0.029)。
对于尚未出现明显背压变化实质表现的患者,EVT可能导致更高的良好住院结局率;梗死、水肿和出血的存在可能会降低EVT的短期有效性。